Texas Tech University Health Sciences Center El Paso has begun a project to identify the genetic factors that cause cerebral cavernous malformations (CCMs) and validate new potential blood biomarkers for early detection. They are seeking to recruit Hispanic CCM patients to donate a blood sample and clinical data. Blood biomarkers will allow us to predict whether a patient is at risk for hemorrhage in the near future, making it easier to decide who is most in need of treatments.